Non-destructive epigenetic sequencing with DNA deaminase enzymes

使用 DNA 脱氨酶进行非破坏性表观遗传测序

基本信息

  • 批准号:
    10186786
  • 负责人:
  • 金额:
    $ 60万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY This proposal aims to establish DNA cytosine deaminase enzymes as a non-destructive alternative to bisulfite for base-resolution mapping of cytosine modifications. Epigenetic modifications to the genome play an important role in cellular adaptation and in specialization of various cell lineages derived from the same coding sequence. On DNA, these epigenetic changes include modification of cytosine bases at the 5-postion of the nucleobase. The most common modification is 5-methylcytosine (5mC), followed closely by 5- hydroxymethylcytosine (5hmC), a product of TET enzyme-mediated oxidation of 5mC. Transformations involved in development, pluripotency and oncogenesis entail changes in the genomic patterns of 5mC and 5hmC, making it important to have robust methods to localize these modifications. The methods most commonly used to detect these modifications involve treatment of genomic DNA with bisulfite, as the different cytosine modification states have a different propensity for bisulfite-induced deamination which can be analyzed by sequencing. Chemical deamination, however, can degrade the vast majority of starting DNA. As a result, bisulfite-based approaches constrain our ability to understand the landscapes of cytosine modifications in many small or transient cell populations, or to study how changes are coordinated across long stretches of genomic DNA. In this proposal, we will develop and apply DNA deaminase-based sequencing approaches that address the major shortcomings of bisulfite. Our methods rely upon enzymatic, rather than chemical deamination, using APOBEC3A (A3A), a DNA deaminase from the immune system repurposed for these biotechnological applications. In our biochemical studies, we have established that A3A potently discriminates between different cytosine modification states, and, in foundational work leading up to this proposal, we developed APOBEC- Coupled Epigenetic Sequencing (ACE-Seq) as a non-destructive, base resolution sequencing method for localizing 5hmC. Building on this precedent, we propose to advance two new DNA deaminase-based sequencing approaches that can now localize 5mC and 5hmC together, providing a surrogate for bisulfite, or to directly detect 5mC alone through deamination, which is without precedent. We will apply these methods to address important biological questions that are refractory to bisulfite-based approaches, specifically resolving C, 5mC and 5hmC to decipher epigenetic heterogeneity at the single cell level, revealing how in cis changes across loci are coordinated across long stretches of DNA, and reporting on the ‘ternary code’ of all three modifications in a single read. Our proposal therefore aims to establish DNA deaminases as a non-destructive and more reliable means for sequencing that can displace bisulfite and its associated limitations, and to thereby drive the widespread adoption of DNA deaminases in epigenetic sequencing in the clinic and the lab.
项目摘要 这项建议旨在建立DNA胞嘧啶脱氨酶作为一种非破坏性的替代亚硫酸氢盐 用于胞嘧啶修饰的碱基分辨率映射。基因组的表观遗传修饰 在细胞适应和来自相同编码的各种细胞谱系的特化中起重要作用 顺序在DNA上,这些表观遗传变化包括在DNA的5位胞嘧啶碱基的修饰, 核碱基最常见的修饰是5-甲基胞嘧啶(5 mC),其次是5-甲基胞嘧啶(5 mC)。 羟甲基胞嘧啶(5 hmC),是泰特酶介导的5 mC氧化的产物。变换 参与发育、多能性和肿瘤发生的基因组模式的改变需要5 mC和 5 hmC,因此拥有强大的方法来定位这些修饰非常重要。方法最 通常用于检测这些修饰的方法包括用亚硫酸氢盐处理基因组DNA, 胞嘧啶修饰状态具有不同的亚硫酸氢盐诱导的脱氨基倾向, 通过测序分析。然而,化学脱氨可以降解绝大多数起始DNA。作为 结果,基于亚硫酸氢盐的方法限制了我们理解胞嘧啶修饰的能力 在许多小的或短暂的细胞群体中,或者研究变化如何在长时间的 基因组DNA 在本提案中,我们将开发和应用基于DNA脱氨酶的测序方法, 亚硫酸氢盐的主要缺点。我们的方法依赖于酶,而不是化学脱氨基,使用 APOBEC 3A(A3 A),一种来自免疫系统的DNA脱氨酶,用于这些生物技术 应用.在我们的生物化学研究中,我们已经确定A3 A可以有效地区分不同的 胞嘧啶修饰状态,并且,在导致这一提议的基础工作中,我们开发了APOBEC- 偶联表观遗传测序(ACE-Seq)是一种非破坏性的碱基分辨率测序方法, 定位于5 hmC。基于这一先例,我们提出了两个新的DNA脱氨酶为基础的 测序方法现在可以将5 mC和5 hmC定位在一起,为亚硫酸氢盐提供替代品,或者 通过脱氨基作用直接单独检测5 mC,这是没有先例的。我们将这些方法应用于 解决了基于亚硫酸氢盐的方法难以解决的重要生物学问题,特别是解决 C、5 mC和5 hmC来解释单细胞水平上的表观遗传异质性,揭示顺式 跨基因座的基因在长段DNA中相互协调,并报告所有三个基因座的“三元密码”。 在一个单一的阅读修改。因此,我们的提案旨在将DNA脱氨酶建立为非破坏性的 和更可靠的测序方法,可以取代亚硫酸氢盐及其相关的限制, 从而推动DNA脱氨酶在临床和实验室的表观遗传测序中的广泛采用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rahul Manu Kohli其他文献

Rahul Manu Kohli的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rahul Manu Kohli', 18)}}的其他基金

Inhibition and Catalytic Degradation of Promutagenic DNA Deaminases
促诱变 DNA 脱氨酶的抑制和催化降解
  • 批准号:
    10729968
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
Engineering Efficient and Controllable Base Editors
工程高效且可控的碱基编辑器
  • 批准号:
    10396080
  • 财政年份:
    2021
  • 资助金额:
    $ 60万
  • 项目类别:
Engineering Efficient and Controllable Base Editors
工程高效且可控的碱基编辑器
  • 批准号:
    10609857
  • 财政年份:
    2021
  • 资助金额:
    $ 60万
  • 项目类别:
Engineering Efficient and Controllable Base Editors
工程高效且可控的碱基编辑器
  • 批准号:
    10796080
  • 财政年份:
    2021
  • 资助金额:
    $ 60万
  • 项目类别:
Engineering Efficient and Controllable Base Editors
工程高效且可控的碱基编辑器
  • 批准号:
    10209723
  • 财政年份:
    2021
  • 资助金额:
    $ 60万
  • 项目类别:
Non-destructive epigenetic sequencing with DNA deaminase enzymes
使用 DNA 脱氨酶进行非破坏性表观遗传测序
  • 批准号:
    9797035
  • 财政年份:
    2019
  • 资助金额:
    $ 60万
  • 项目类别:
Non-destructive epigenetic sequencing with DNA deaminase enzymes
使用 DNA 脱氨酶进行非破坏性表观遗传测序
  • 批准号:
    10004705
  • 财政年份:
    2019
  • 资助金额:
    $ 60万
  • 项目类别:
Combating Bacterial Drug Resistance by Targeting the Enzymes of Evolution
通过针对进化酶来对抗细菌耐药性
  • 批准号:
    8355227
  • 财政年份:
    2012
  • 资助金额:
    $ 60万
  • 项目类别:
Elucidating the Chemistry and Biology of Nucleic Acid Cytidine Deaminases in HIV
阐明 HIV 核酸胞苷脱氨酶的化学和生物学
  • 批准号:
    8136827
  • 财政年份:
    2010
  • 资助金额:
    $ 60万
  • 项目类别:
Elucidating the Chemistry and Biology of Nucleic Acid Cytidine Deaminases in HIV
阐明 HIV 核酸胞苷脱氨酶的化学和生物学
  • 批准号:
    8604126
  • 财政年份:
    2010
  • 资助金额:
    $ 60万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 60万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 60万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 60万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 60万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 60万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 60万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了